http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2733359-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57b7b2446fae277e03b6fa11fe675df0 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30 |
filingDate | 2014-09-05^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-11-28^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7805f9d42e111c93e7329fcff40874c |
publicationDate | 2019-11-28^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2733359-T3 |
titleOfInvention | Risk stratification of patients suspected of AMI |
abstract | A method of risk stratifying a subject presenting with chest pain suspected to be ischemic in nature, wherein said subject has a negative ECG, said method comprising determining levels of a cardiac troponin and H- FABP in an in vitro sample taken from the subject at presentation where the reference value for a cardiac troponin to rule out acute myocardial infarction (AMI) is the 99th percentile of a reference population, and where the reference value for H-FABP to rule out an AMI is the 95th percentile of a reference population, and based on these results, calculating the subject's probability of having suffered an AMI and the risk stratification of said patient accordingly. |
priorityDate | 2013-09-06^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 55 of 55.